Library
PubMed
research article
Professional

Clinical analysis of preoperative and postoperative anxiety and depression in patients with proximal humeral fractures.

Source: PubMed, NCBI / U.S. National Library of Medicine

BMC psychologyQi Hongfei, Li Zhong, Lin Hua, et al.Published 6/6/2026Last synced 6/6/2026Status: syncedPMID: 42249435DOI: 10.1186/s40359-026-04937-0

This study aimed to investigate the incidence of anxiety and depressive emotions in patients with proximal humeral fractures rehabilitation plans. A retrospective analysis was conducted on the clinical data of 89 patients with proximal humeral fractures from January 2022 to December 2023. According to the preoperative scores of the Hospital Anxiety and Depression Scale (HADS), 42 patients with anxiety/depressive symptoms were assigned to the observation group, and 47 patients without such symptoms were included in the control group. The changes of various indicators and prognostic differences between the two groups before and after surgery were compared, and the correlation between preoperative anxiety and depression and surgical prognosis was analyzed. Among the 89 patients with proximal humeral fractures, the incidence of preoperative anxiety/depressive symptoms was 47.19% (42/89). Both groups showed significant improvements in pain, psychological status, and shoulder function (all P&#x2009;<&#x2009;0.05). The observation group had higher preoperative and final follow-up VAS and HADS scores, and lower ASES scores (all P&#x2009;<&#x2009;0.05). The improvement ranges of postoperative VAS, HADS-A and HADS-D scores in the observation group were significantly larger than those in the control group (P&#x2009;<&#x2009;0.05). Correlation analysis showed that the total preoperative HADS score was significantly negatively correlated with the postoperative ASES score (r=-0.426, P&#x20

Abstract

This study aimed to investigate the incidence of anxiety and depressive emotions in patients with proximal humeral fractures rehabilitation plans. A retrospective analysis was conducted on the clinical data of 89 patients with proximal humeral fractures from January 2022 to December 2023. According to the preoperative scores of the Hospital Anxiety and Depression Scale (HADS), 42 patients with anxiety/depressive symptoms were assigned to the observation group, and 47 patients without such symptoms were included in the control group. The changes of various indicators and prognostic differences between the two groups before and after surgery were compared, and the correlation between preoperative anxiety and depression and surgical prognosis was analyzed. Among the 89 patients with proximal humeral fractures, the incidence of preoperative anxiety/depressive symptoms was 47.19% (42/89). Both groups showed significant improvements in pain, psychological status, and shoulder function (all P&#x2009;<&#x2009;0.05). The observation group had higher preoperative and final follow-up VAS and HADS scores, and lower ASES scores (all P&#x2009;<&#x2009;0.05). The improvement ranges of postoperative VAS, HADS-A and HADS-D scores in the observation group were significantly larger than those in the control group (P&#x2009;<&#x2009;0.05). Correlation analysis showed that the total preoperative HADS score was significantly negatively correlated with the postoperative ASES score (r=-0.426, P&#x2009;<&#x2009;0.001), and significantly positively correlated with the postoperative VAS score (r&#x2009;=&#x2009;0.389, P&#x2009;<&#x2009;0.001). Preoperative anxiety and depression are highly prevalent in patients with proximal humeral fractures and are associated with poorer postoperative pain relief and shoulder function recovery. Surgical treatment effectively improves both physical and psychological conditions, with more pronounced improvements observed in patients with preoperative psychological distress. Routine preoperative psychological screening and targeted intervention are recommended to optimize surgical prognosis.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.